Literature DB >> 9414961

Intestinal metaplasia at the squamocolumnar junction in patients attending for diagnostic gastroscopy.

N J Trudgill1, S K Suvarna, K C Kapur, S A Riley.   

Abstract

BACKGROUND: The incidence of adenocarcinoma of the oesophagus and gastric cardia is increasing rapidly. Barrett's oesophagus is the major risk factor. Intestinal metaplasia at the squamocolumnar junction in the absence of Barrett's oesophagus is common but its relation to adenocarcinoma and gastro-oesophageal reflux disease is unclear. AIMS: To study the prevalence and clinical, endoscopic, and histological associations of intestinal metaplasia at the squamocolumnar junction.
METHODS: Biopsy specimens were taken from 120 randomly selected patients undergoing routine diagnostic endoscopy. Eight biopsy specimens, taken from above and below the squamocolumnar junction, gastric fundus, and gastric antrum, were stained with haematoxylin/eosin, alcian blue/periodic acid-Schiff, and Gimenez, and graded independently by one pathologist.
RESULTS: Intestinal metaplasia at the squamocolumnar junction was found in 21 patients (18%). Metaplasia was associated with increasing age (p < 0.01) and antral intestinal metaplasia (p = 0.04). Logistic regression analysis revealed that age was the only independent predictor (p < 0.01). There was no association with symptomatic, endoscopic, or histological markers of gastro-oesophageal reflux disease.
CONCLUSIONS: Intestinal metaplasia at the squamocolumnar junction is a common finding. It is associated with increasing age but not gastro-oesophageal reflux disease.

Entities:  

Mesh:

Year:  1997        PMID: 9414961      PMCID: PMC1891581          DOI: 10.1136/gut.41.5.585

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  22 in total

1.  The histologic spectrum of Barrett's esophagus.

Authors:  A Paull; J S Trier; M D Dalton; R C Camp; P Loeb; R K Goyal
Journal:  N Engl J Med       Date:  1976-08-26       Impact factor: 91.245

2.  Endoscopic and biopsy criteria for the diagnosis of esophagitis with a fiberoptic esophagoscope.

Authors:  S Kobayashi; T Kasugai
Journal:  Am J Dig Dis       Date:  1974-04

3.  Barrett esophagus: the columnar-epithelial-lined lower esophagus.

Authors:  J N Burgess; W S Payne; H A Andersen; L H Weiland; H C Carlson
Journal:  Mayo Clin Proc       Date:  1971-11       Impact factor: 7.616

4.  Sampling error and observer variation in the interpretation of esophageal biopsies.

Authors:  B Adami; V F Eckardt; K Paulini
Journal:  Digestion       Date:  1979       Impact factor: 3.216

5.  Mucosal biopsy of the esophagus, stomach, and proximal duodenum.

Authors:  H Goldman; D A Antonioli
Journal:  Hum Pathol       Date:  1982-05       Impact factor: 3.466

6.  Adenocarcinoma complicating columnar epithelium-lined (Barrett's) esophagus.

Authors:  R C Haggitt; J Tryzelaar; F H Ellis; H Colcher
Journal:  Am J Clin Pathol       Date:  1978-07       Impact factor: 2.493

7.  Bile reflux and intestinal metaplasia in gastric mucosa.

Authors:  G M Sobala; H J O'Connor; E P Dewar; R F King; A T Axon; M F Dixon
Journal:  J Clin Pathol       Date:  1993-03       Impact factor: 3.411

8.  Prevalence and characteristics of Barrett esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction.

Authors:  S R Hamilton; R R Smith; J L Cameron
Journal:  Hum Pathol       Date:  1988-08       Impact factor: 3.466

9.  Symptoms in gastro-oesophageal reflux disease.

Authors:  A G Klauser; N E Schindlbeck; S A Müller-Lissner
Journal:  Lancet       Date:  1990-01-27       Impact factor: 79.321

10.  Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites.

Authors:  J Powell; C C McConkey
Journal:  Br J Cancer       Date:  1990-09       Impact factor: 7.640

View more
  22 in total

Review 1.  Gastro-oesophageal reflux disease and Helicobacter pylori: an intricate relation.

Authors:  D McNamara; C O'Morain
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

2.  Increased Barrett's esophagus for the decade between 1991 and 2000 at a single university medical center.

Authors:  Shayan Irani; Henry P Parkman; Rebecca Thomas; Benjamin Krevsky; Robert S Fisher; Peter Axelrod
Journal:  Dig Dis Sci       Date:  2005-11       Impact factor: 3.199

Review 3.  The interplay between Helicobacter pylori, gastro-oesophageal reflux disease, and intestinal metaplasia.

Authors:  P Malfertheiner; U Peitz
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

4.  Short-Segment Barrett's Esophagus and Adenocarcinoma.

Authors:  Amit Rastogi; Prateek Sharma
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-02

5.  Diffusion of cytotoxic concentrations of nitric oxide generated luminally at the gastro-oesophageal junction of rats.

Authors:  K Asanuma; K Iijima; H Sugata; S Ohara; T Shimosegawa; T Yoshimura
Journal:  Gut       Date:  2005-04-28       Impact factor: 23.059

Review 6.  Trends in incidence and prevalence of specialized intestinal metaplasia, barrett's esophagus, and adenocarcinoma of the gastroesophageal junction.

Authors:  Manuel Pera
Journal:  World J Surg       Date:  2003-08-18       Impact factor: 3.352

Review 7.  Effect of Helicobacter pylori infection in Barrett's esophagus and the genesis of esophageal adenocarcinoma.

Authors:  Geoffrey W B Clark
Journal:  World J Surg       Date:  2003-07-24       Impact factor: 3.352

8.  Studies of acid exposure immediately above the gastro-oesophageal squamocolumnar junction: evidence of short segment reflux.

Authors:  J Fletcher; A Wirz; E Henry; K E L McColl
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

Review 9.  Barrett's esophagus: histopathologic definitions and diagnostic criteria.

Authors:  James Mueller; Martin Werner; Manfred Stolte
Journal:  World J Surg       Date:  2004-01-20       Impact factor: 3.352

10.  Histopathology of the endoscopic esophagogastric junction in patients with gastroesophageal reflux disease.

Authors:  Claudia Ringhofer; Johannes Lenglinger; Barbara Izay; Katharina Kolarik; Johannes Zacherl; Margit Eisler; Fritz Wrba; Parakrama T Chandrasoma; Enrico P Cosentini; Gerhard Prager; Martin Riegler
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.